Publication Frequency
Semi-annual
Journal Content
Search
Search scope
Journal Center
Asia Pacific Academy of Science Pte. Ltd. (APACSCI) specializes in international journal publishing. APACSCI adopts the open access publishing model and provides an important communication bridge for academic groups whose interest fields include engineering, technology, medicine, computer, mathematics, agriculture and forestry, and environment.
Volume Arrangement
2025
Featured Articles
Historically, the heart has been considered a vital organ due to its function as an impeller and aspirating blood pump, allowing the fi siological perfusion to every corner of the human body. However, behind this pump role lies a little-discussed function, that is, the endocrine-metabolic role of the heart, as a hormone synthesizing organ and, because of its pump function, a distributor of hormones foreign to it. Understanding the incidence of peptides synthesized in the heart offers a new perspective on the relevance of the heart in homeostasis and how cardiovascular disease can alter metabolism. The present work aims to review the most current information on the role of natriuretic peptides produced in the heart and their endocrine-metabolic function. These are atrial, brain and C-type natriuretic peptides. It is concluded that the conception of the heart as an organ of endocrine-metabolic regulation, whose hormones are essential for the homeostasis of the organism, is fundamental for the medicine of this century and for future advances in new therapeutic strategies to improve the quality of life of patients.
Coronavirus and cardiovascular system
Article ID: 1905
Vol 2, Issue 2, 2021
DOI: https://doi.org/10.54517/ccr.v2i2.1905
Vol 2, Issue 2, 2021
Received: 6 July 2021; Accepted: 21 August 2021; Available online: 6 September 2021; Issue release: 31 December 2021
Download PDF
Abstract
The current pandemic caused by the new coronavirus (SARS-CoV-2) has been the focus of worldwide health concern since its appearance. Its high transmissibility associated with the absence of an effective treatment implies a hard impact in the research area. Reports on atypical forms of presentation, associated risk factors and drugs tested to reduce morbidity and mortality saturate the media. The cardiological community is actively involved, since cardiovascular manifestations are frequent and varied, and an increased risk of poor outcome has been observed in individuals with previous cardiovascular disease. The aim of the review is to provide the available evidence on this topic, with the caveat that the information is dynamic.
Keywords
SARS-COV-2; COVID-19; cardiovascular disease
References
- Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the Coronavirus Disease 2019 (COVID-19) Pandemic. J Am Coll Cardiol. 2020. doi: 10.1016/j. jacc.2020.03.031
- Case viewer. Available online: https://www.gub.uy/sis- tema-nacional-emergencias/ (accessed on 24 April 2021).
- Fried JA, Ramasubbu K, Bhatt R, et al. The Variety of Cardiovascular Presentations of COVID-19. Circulation. 2020; 141(23): 1930-1936. doi: 10.1161/circulationaha.120.047164
- Tan W, Aboulhosn J. The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease. International Journal of Cardiology. 2020; 309: 70-77. doi: 10.1016/j.ijcard.2020.03.063
- Cascella M, Rajnik M, Cuomo A, et al. Features, evaluation and treatment coronavirus (COVID-19). Available online: https://www.ncbi.nlm.nih.gov/books/NBK554776/ (accessed on 24 April 2021).
- Akhmerov A, Marbán E. COVID-19 and the Heart. Circulation Research. 2020; 126(10): 1443-1455. doi: 10.1161/circresaha.120.317055
- Zhou F, Yu T, Du R, et al. Clinical course and risk factorsfor mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229): 1054-1062. doi: 10.1016/S0140-6736(20) 30566-3
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020. doi: 10.1001/ jama.2020.1585
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
- Shi S, Qin M, Shen B, et al. Association of Cardiac Injury with Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA. 2020. doi: 10.1001/jamacar- dio.2020.0950
- Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020; 323(13): 1239. doi: 10.1001/jama.2020.2648
- Libby P, Ridker PM, Hansson GK. Inflammation in Atherosclerosis. Journal of the American College of Cardiology. 2009; 54(23): 2129-2138. doi: 10.1016/j.jacc.2009.09.009
- Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nature Reviews Cardiology. 2020; 17(5): 259-260. doi: 10.1038/s41569-020-0360-5
- McMurray J, Pfeffer M, Solomon S. Renin-angio-angio- tensin-aldosterone system inhibitors in patients with COVID-19. N Engl J Med. 2020; 382(17). doi: 10. 1056/NEJMsr2005760
- Zhang P, Zhu L, Cai J, et al. Association of inpatient use of angiotensin converting enzyme inhibitors and Angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circ Res. 2020; 127(6): e147. doi: 10.1161/RES.0000000000000434
- Frankie Tam C, Cheung K, Lam S, et al. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China. Circulation: Cardiovascular Quality and Outcomes. 2020; 13(4). doi: 10.1161/circoutcomes.120.006631
- Alhogbani T. Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus. Ann Saudi Med. 2016; 36(1): 78-80. doi: 10.5144/ 0256-4947.2016.78
- Zeng JH, Liu YX, Yuan J, et al. First Case of COVID-19 Infection with Fulminant Myocarditis Complication: Case Report and Insights. Published online March 11, 2020. doi: 10.20944/preprints202003.0180.v1
- Xiong TY, Redwood S, Prendergast B, et al. Coronaviruses and the cardiovascular system: acute and long-term implications. European Heart Journal. 2020; 41(19): 1798-1800. doi: 10.1093/eurheartj/ehaa231
- Bangalore S, Sharma A, Slotwiner A, et al. ST-Segment Elevation in Patients with Covid-19—A Case Series. New England Journal of Medicine. 2020; 382(25): 2478-2480. doi: 10.1056/nejmc2009020
- Romaguera R, Cruz-González I, Jurado-Román A, et al. Considerations on the invasive approach to ischemic and structural heart disease during the COVID-19 coronavirus outbreak. Consensus document of the Association of Interventional Cardiology and the Association of Ischemic Heart Disease and Acute Cardiovascular Care of the Spanish Society of Cardiology. REC Interv Cardiol. 2020. doi: 10.24875/RECIC.M20000119
- Mahmud E, Dauerman HL, Welt FGP, et al. Management of acute myocardial infarction during the COVID-19 pandemic. J Am Coll Cardiol. 2020. doi: 10.1016/j. jacc.2020.04.039
- Lazzerini P, Boutjdir M, Capecchi PL. COVID-19, arrhythmic risk and inflammation: Mind the Gap! Circulation. 2020. doi: 10.1161/CIRCULA-TIONAHA.120.047293
- Vidovich MI. Transient Brugada-Like Electrocardiographic Pattern in a Patient With COVID-19. JACC: Case Reports. 2020; 2(9): 1245-1249. doi: 10.1016/j.jaccas.2020.04.007
- Lazzerini PE, Capecchi PL, Laghi-Pasini F. Systemic inflammation and arrhythmic risk: lessons from rheumatoid arthritis. European Heart Journal. Published online June 1, 2016: ehw208. doi: 10.1093/eurheartj/ehw208
- Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and Follow-up. J Am Coll Cardiol. 2020. doi: 10.1016/j.jacc. 2020.04.031
- Ciceri F, Beretta L, Scandroglio AM, et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Critical Care and Resuscitation. 2020; 22(2): 95-97. doi: 10.51893/2020.2.pov2
- Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients in severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020. doi: 10.1007/s00134-020- 06062-x
Refbacks
- There are currently no refbacks.
Copyright (c) 2021 Dres Sofía Noria, Juan Pablo Bachini, María Victoria Ramos
This work is licensed under a Creative Commons Attribution 4.0 International License.
This site is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).
Editor-in-Chief
Prof. Prakash Deedwania
University of California,
San Francisco, United States
Indexing and Archiving
News & Announcements
2024-09-08
September 16: International Day of Interventional Cardiology
WInternational Interventional Cardiology Day aims to raise public awareness of cardiovascular disease and surgery, related complications, and prevention and care.
2024-06-21
Welcome Our New Editorial Board Members
We are delighted to welcome these experts to our Editorial Board for Cardiac and Cardiovascular Research.
2024-01-01
Updates Author Guidelines for our journal
We are excited to announce the release of our updated "Author Guidelines" for Cardiac and Cardiovascular Research.
